PIWIL4 and neoplasm: In the multivariate analysis, low PIWIL4 expression remained statistically significant for a higher risk of progression (HR = 2.036; 95% CI: 1.025–4.044; p = 0.042) together with tumor size (HR = 3.095; 95% CI: 1.237–7.744; p = 0.016).